We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHITE DETAILS PhRMA'S PLAN TO STOP REIMPORTATION, PRICE CONTROLS
WHITE DETAILS PhRMA'S PLAN TO STOP REIMPORTATION, PRICE CONTROLS
April 7, 2004
Faced with growing pressure in Congress on the issue of drug prices, the new chairman of PhRMA has announced a three-point platform that includes greater price transparency as part of an effort to help Americans lower their healthcare costs without resorting to drug reimportation or price controls.